Renin system activity as a determinant of response to treatment in hypertension and heart failure.
- 1 September 1983
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 5 (5_pt_2), III36-42
- https://doi.org/10.1161/01.hyp.5.5_pt_2.iii36
Abstract
In hypertension, irrespective of its underlying etiology, the baseline pretreatment renin-sodium profile predicts the antihypertensive action or the lack of it for five major types of antihypertensive drugs: 1) diuretic agents; 2) beta-receptor blockers; 3) converting-enzyme inhibitors; 4) the alpha 1 postsynaptic blocker, prazosin; and 5) the calcium channel blockers, verapamil and nifedipine. Moreover, vigorous compensatory activation of the renin-angiotensin system in response to therapy often explains initial drug ineffectiveness or resistance to treatment by diuretics and nonspecific vasodilators. This correlation between renin system behavior and antihypertensive drug efficacy likely reflect basic pharmacologic-physiologic interactions. This correlation is also observed in congestive heart failure without hypertension, where operant renin-aldosterone profiles may help to explain both drug efficacy and drug resistance to commonly administered therapeutic agents. Accordingly, a control system analysis of the renin axis has broad applications in therapy. The analysis is also conceptually significant since it exposes the operation of fundamentally different mechanisms of increased vascular resistance to flow occurring in different patients with hypertension or heart failure. One form is renin-angiotensin-mediated whereas the other, in the absence of renin, is associated with sodium-volume excess and/or abnormal alpha-adrenergic and calcium channel activity. Further definition of these two mechanisms of increased peripheral resistance could lead to a better understanding of the pathogenesis of some forms of essential hypertension and congestive heart failure.Keywords
This publication has 18 references indexed in Scilit:
- Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failureAmerican Heart Journal, 1982
- The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: Response to specific inhibitors (prazosin and captopril)The American Journal of Cardiology, 1982
- Heterogeneity of Postjunctional Vascular α-Adrenoceptors and Handling of CalciumJournal of Cardiovascular Pharmacology, 1982
- The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatmentProgress in Cardiovascular Diseases, 1978
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeThe New England Journal of Medicine, 1977
- Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profilesAmerican Journal Of Medicine, 1973
- Volume factor in low and normal renin essential hypertension: Treatment with either spironolactone or chlorthalidoneThe American Journal of Cardiology, 1973
- Angiotensin-Sodium Interaction in Blood Pressure Maintenance of Renal Hypertensive and Normotensive RatsScience, 1973
- Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular diseaseAmerican Journal Of Medicine, 1972
- Effect of Spironolactone in Hypertensive PatientsThe American Journal of the Medical Sciences, 1970